Open AccessCandidate for a live vaccine?
Author(s) -
Justin Abbatemarco,
Alan J. Taege
Publication year - 2017
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_67_17
Subject(s) - medicine , vaccination , immune dysfunction , varicella zoster virus , window of opportunity , immune status , varicella vaccine , intensive care medicine , pediatrics , immune system , immunology , virus , immunization , real time computing , computer science
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination.